A private equity consortium of Warburg Pincus and Advent International is said to be in advanced talks to acquire medical device maker Baxter International’s biopharma...
Plans by US healthcare company Baxter International to shed its biopharma contract business as it streamlines operations after a poor 2022 earnings performance are...
05.09.2019
- Swiss fine chemicals producer Lonza has signed a contract manufacturing agreement with Korea-based biosimilars producer Celltrion to supply a drug substance for Remsima, a...
28.02.2017
- UK pharmaceutical group Mundipharma is gearing up to launch Truxima (rituximab), a biosimilar from South Korea’s Celltrion, for the treatment of certain cancers and inflammatory...
07.02.2014
- Pharmaceuticals - Many biologic drug developers can be pleased with how well their products have performed in the market place. Blockbuster products such as Abbvie's (ex-Abbott)...
01.07.2013
- European regulators have cleared the way for the first serious threat to the makers of multibillion-dollar biotechnology drugs to treat diseases such as cancer and rheumatoid...
